Literature DB >> 23277204

Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx.

Zengxin Lu1, Guohui Wan, Huarong Guo, Xinna Zhang, Xiongbin Lu.   

Abstract

The activation and stabilization of the p53 protein play a major role in the DNA damage response. Protein levels of p53 are tightly controlled by transcriptional regulation and a number of positive and negative posttranslational modifiers, including kinases, phosphatases, E3 ubiquitin ligases, deubiquitinases, acetylases and deacetylases. One of the primary p53 regulators is Mdmx. Despite its RING domain and structural similarity with Mdm2, Mdmx does not have an intrinsic ligase activity, but inhibits the transcriptional activity of p53. Previous studies reported that Mdmx is phosphorylated and destabilized in response to DNA damage stress. Three phosphorylation sites identified are Ser342, Ser367, and Ser403. In the present study, we identify protein phosphatase 1 (PP1) as a negative regulator in the p53 signaling pathway. PP1 directly interacts with Mdmx and specifically dephosphorylates Mdmx at Ser367. The dephosphorylation of Mdmx increases its stability and thereby inhibits p53 activity. Our results suggest that PP1 is a crucial component in the ATM-Chk2-p53 signaling pathway.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277204      PMCID: PMC3595384          DOI: 10.1016/j.cellsig.2012.12.014

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  39 in total

1.  Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage.

Authors:  Qian Cheng; Brittany Cross; Baozong Li; Lihong Chen; Zhenyu Li; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

2.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 3.  The DNA damage response: ten years after.

Authors:  J Wade Harper; Stephen J Elledge
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

4.  The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

Authors:  Xiongbin Lu; Ou Ma; Thuy-Ai Nguyen; Stephen N Jones; Moshe Oren; Lawrence A Donehower
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

Review 5.  From promiscuity to precision: protein phosphatases get a makeover.

Authors:  David M Virshup; Shirish Shenolikar
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

6.  A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis.

Authors:  Guillermo Flores-Delgado; Cathy W Y Liu; Richard Sposto; Norbert Berndt
Journal:  J Proteome Res       Date:  2007-02-03       Impact factor: 4.466

Review 7.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

8.  Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.

Authors:  Xinna Zhang; Guohui Wan; Sizolwenkosi Mlotshwa; Vicki Vance; Franklin G Berger; Hexin Chen; Xiongbin Lu
Journal:  Cancer Res       Date:  2010-07-28       Impact factor: 12.701

9.  Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response.

Authors:  Xinna Zhang; Lin Lin; Huarong Guo; Jianhua Yang; Stephen N Jones; Aart Jochemsen; Xiongbin Lu
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

Review 10.  The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.

Authors:  Xiongbin Lu; Thuy-Ai Nguyen; Sung-Hwan Moon; Yolanda Darlington; Matthias Sommer; Lawrence A Donehower
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

View more
  7 in total

1.  Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects.

Authors:  Kara L McKinley; Iain M Cheeseman
Journal:  Dev Cell       Date:  2017-02-16       Impact factor: 12.270

2.  Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Chunsun Li; Miaomiao Wu; Guijuan Zong; Chunhua Wan; Qingqing Liu; Huiling Zhou; Lu Hua; Yuyan Chen; Xudong Chen; Cuihua Lu
Journal:  Dig Dis Sci       Date:  2016-12-05       Impact factor: 3.199

3.  Phosphatases reverse p53-mediated cell cycle checkpoints.

Authors:  Lawrence A Donehower
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-07       Impact factor: 11.205

4.  Scalable Nonparametric Prescreening Method for Searching Higher-Order Genetic Interactions Underlying Quantitative Traits.

Authors:  Juho A J Kontio; Mikko J Sillanpää
Journal:  Genetics       Date:  2019-10-04       Impact factor: 4.562

5.  Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.

Authors:  Arun H Shastry; Balaram Thota; Mallavarapu R Srividya; Arimappamagan Arivazhagan; Vani Santosh
Journal:  Pathol Oncol Res       Date:  2015-08-09       Impact factor: 3.201

6.  SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.

Authors:  María Galindo-Moreno; Servando Giráldez; M Cristina Limón-Mortés; Alejandro Belmonte-Fernández; Steven I Reed; Carmen Sáez; Miguel Á Japón; Maria Tortolero; Francisco Romero
Journal:  FASEB J       Date:  2019-07-23       Impact factor: 5.834

7.  Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer.

Authors:  Andreas Marx; Andreas M Luebke; Till S Clauditz; Stefan Steurer; Christoph Fraune; Claudia Hube-Magg; Franziska Büscheck; Doris Höflmayer; Maria Christina Tsourlakis; Christina Möller-Koop; Ronald Simon; Guido Sauter; Cosima Göbel; Patrick Lebok; David Dum; Simon Kind; Sarah Minner; Jakob Izbicki; Thorsten Schlomm; Hartwig Huland; Hans Heinzer; Eike Burandt; Alexander Haese; Markus Graefen; Jan Meiners
Journal:  Dis Markers       Date:  2020-04-25       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.